Hotline 24/7: 0909384389

Share links:

Robocath completes European study of robot-assisted PCI

Ngày 13/01/2022 01:50 | Lượt xem: 858

Robocath has announced the conclusion of its R-Evolution clinical study in Europe, which was aimed at assessing the safety and efficacy of the R-One robotic assistance platform for percutaneous coronary intervention (PCI) procedures.

Sixty-two patients across six European hospital centres participated: the University Hospitals in Rouen and Caen and Clinique Pasteur, Toulouse, France, the ZNA Middelheim Hospital in Antwerp, Belgium, the Maasstad Clinic in Rotterdam, The Netherlands, and the National Interventional Cardiac Surgery Institute in Luxembourg. The last patient was enrolled on October 8, 2021, at the Caen University Hospital Center. Full results of the study are due in May 2022 and will be presented at the EuroPCR conference.

Eric Durand, interventional cardiologist at the Rouen University Hospital Center and joint principal investigator for the study, said: “I feel honoured to have had the chance to be joint principal investigator of the R-Evolution clinical study. I have been involved in the development of this robotic platform since the beginning, with Prof Remi Sabatier from the University Hospital of Caen. I was able to participate in the development, preclinical studies and first-in-human procedures with R-One.

“The robot is intuitive, easy to understand and offers a very fast learning curve. Beyond that, as well as being more precise than working by hand, it also opens the door to new manoeuvres. These clinical cases have strengthened my belief that vascular robotics is a necessary development in our sector and that it will allow us to offer high-quality treatment to all patients within a work environment that is far superior, for both physicians and their teams.”

Jean Fajadet, interventional cardiologist at the Clinique Pasteur in Toulouse and joint principal investigator for the study, said: “Robotics is, in all likelihood, the future of interventional cardiology; there is no doubt in my mind that this study will prove that. Vascular robotics now allows us to position a stent with millimetre precision and place it safely, as the robot holds and guides the instruments throughout the procedure. The movement is fluid and usage is intuitive. The system offers overall working conditions that are far more comfortable than operations carried out by hand and completely protects the physician from X-rays.

“Robotics will eventually enable us to complete more complex procedures and will be the main vector for global integration and transformation in cath labs. This will enhance healthcare sites’ attractiveness by improving the quality of care provided to patients. I am delighted to be one of the first interventional cardiologists in the world to work with this significant technological advance in our sector.”

Philippe Bencteux, president and founder of Robocath, added: “The conclusion of the R-Evolution study marks the end of years of hard work and investment by everyone involved and I am grateful to all of them. We are genuinely on the cusp of a new era in vascular medicine. As the founder of the company, I am delighted to see our vision coming to life.”

Lucien Goffart, CEO of Robocath concluded: “We have once again reached a crucial milestone in our company’s history. This is the result of a vibrant and productive partnership between the hospital centers and the Robocath staff, who have worked incredibly hard against the backdrop of the current medical context. They all have my most sincere thanks. Vascular robotics has immense potential for use. We now plan to capitalise further on the clinical experience with our product to accelerate our growth in Europe by opening a Europe-wide observational registry.”

Source CardiovascularNews

Duc Tin Clinic

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support